Ischemic Attack, Transient

• 

  Subject Areas on Research

  • A follow-up survey of clinical practices for the use of heparin, warfarin, and aspirin. 
  • A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease. 
  • A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial. 
  • Absence of electrographic seizures after transient forebrain ischemia in the Mongolian gerbil. 
  • Accuracy of ICD-9-CM Codes by Hospital Characteristics and Stroke Severity: Paul Coverdell National Acute Stroke Program. 
  • Additional Factors in Considering Patent Foramen Ovale Closure to Prevent Recurrent Ischemic Stroke. 
  • Advances in Stroke: Treatments-Preventive. 
  • Alterations in the gamma-aminobutyric acid-gated chloride channel following transient forebrain ischemia in the gerbil. 
  • An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE Trial. 
  • Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus. 
  • Antiplatelet Use and Ischemic Stroke Risk in Minor Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the POINT Trial. 
  • Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. 
  • Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. 
  • Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack. 
  • Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. 
  • Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial. 
  • Association of Osteopontin, Neopterin, and Myeloperoxidase With Stroke Risk in Patients With Prior Stroke or Transient Ischemic Attacks: Results of an Analysis of 13 Biomarkers From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial. 
  • Association of Smoking Status With Long-Term Mortality and Health Status After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. 
  • Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. 
  • Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL Trial. 
  • Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study. 
  • Biomarker-based risk prediction in the community. 
  • Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. 
  • COMPASS-CP: An Electronic Application to Capture Patient-Reported Outcomes to Develop Actionable Stroke and Transient Ischemic Attack Care Plans. 
  • Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy. 
  • Cardiopulmonary bypass and the central nervous system: potential for cerebral protection. 
  • Cardiovascular Risk Factor Profiles, Emergency Department Visits, and Hospitalizations for Women and Men with a History of Stroke or Transient Ischemic Attack: A Cross-Sectional Study. 
  • Cerebral aneurysms: mechanisms of injury and critical care interventions. 
  • Cerebral hemodynamics and cognitive impairment: baseline data from the RECON trial. 
  • Changes in superoxide dismutase and catalase activities of rat brain regions during early global transient ischemia/reperfusion. 
  • Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. 
  • Characterization of a recovery global cerebral ischemia model in the mouse. 
  • Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial. 
  • Characterization of the ubiquitin-modified proteome regulated by transient forebrain ischemia. 
  • Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings. 
  • Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. 
  • Clinical Characteristics, Management, and In-Hospital Outcomes in Patients With Stroke or Transient Ischemic Attack in China. 
  • Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials. 
  • Comparison of amaurosis fugax and transient cerebral ischemia: a prospective clinical and arteriographic study. 
  • Comparison of the effects of propofol and pentobarbital on neurologic outcome and cerebral infarct size after temporary focal ischemia in the rat. 
  • Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS). 
  • Concerns for the reliability and validity of the National Stroke Project Stroke Severity Scale. 
  • Concomitant carotid endarterectomy and cardiac surgery does not decrease postoperative stroke rates. 
  • Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Cranial nerve paralysis following carotid endarterectomy. 
  • Current Debates on the Treatment of Carotid Stenosis in Both Symptomatic and Asymptomatic Patients: A Reappraisal. 
  • Death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic stroke-longitudinal registry. 
  • Decision making in the face of uncertainty: the case of carotid endarterectomy. 
  • Depressed responses to applied and synaptically-released GABA in CA1 pyramidal cells, but not in CA1 interneurons, after transient forebrain ischemia. 
  • Depression and antidepressant use after stroke and transient ischemic attack. 
  • Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial. 
  • Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. 
  • Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). 
  • Development and validation of an automated algorithm for end point adjudication for a large U.S. national registry. 
  • Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia. 
  • Diagnostic evaluation of the carotid arteries. Health and Public Policy Committee, American College of Physicians. 
  • Diffusion MR imaging and transient ischemic attacks. 
  • Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study. 
  • Early carotid artery stenting and angioplasty in patients with acute ischemic stroke. 
  • Echocardiography for the detection of cardiac sources of embolism in patients with stroke or transient ischemic attack. 
  • Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial. 
  • Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. 
  • Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke: CHANCE substudy. 
  • Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. 
  • Effect of transient cerebral ischemia on gamma-aminobutyric acidA receptor alpha 1-subunit-immunoreactive interneurons in the gerbil CA1 hippocampus. 
  • Effectiveness and safety of carotid artery stenting for significant carotid stenosis in patients with contralateral occlusion (from the German ALKK-CAS Registry experience). 
  • Effects of NMDA receptor antagonists and body temperature in the gerbil carotid occlusion model of transient forebrain ischemia. 
  • Effects of RSR13, a synthetic allosteric modifier of hemoglobin, alone and in combination with dizocilpine, on outcome from transient focal cerebral ischemia in the rat. 
  • Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Effects of postischemic halothane administration on outcome from transient focal cerebral ischemia in the rat. 
  • Efficacy of clopidogrel for stroke depends on CYP2C19 genotype and risk profile. 
  • Elderly women have lower rates of stroke, cardiovascular events, and mortality after hospitalization for transient ischemic attack. 
  • Electron microscopic study of the gerbil dentate gyrus after transient forebrain ischemia. 
  • Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. 
  • Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke. 
  • Evaluation of novel ECG signal processing on quantification of transient ischemia and baseline wander suppression. 
  • Executive function deficits in acute stroke. 
  • Exploration of a hypothesized independent association of a common 9p21.3 gene variant and ischemic stroke in patients with and without angiographic coronary artery disease. 
  • Extracellular ions, hypoxic irreversible loss of function and delayed postischemic neuron degeneration studied in vitro. 
  • Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. 
  • Extracranial-intracranial bypass surgery: hemodynamic and metabolic effects. 
  • First-Ever Stroke and Transient Ischemic Attack Incidence and 30-Day Case-Fatality Rates in a Population-Based Study in Argentina. 
  • Glycine antagonism does not block ischemic spontaneous depolarization in the rat. 
  • Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. 
  • Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. 
  • Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. 
  • HVAD: The ENDURANCE Supplemental Trial. 
  • Health status of individuals with mild stroke. 
  • High-dose atorvastatin after stroke or transient ischemic attack. 
  • Hospital Readmissions and Mortality Among Fee-for-Service Medicare Patients With Minor Stroke or Transient Ischemic Attack: Findings From the COMPASS Cluster-Randomized Pragmatic Trial. 
  • Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial. 
  • Hypothermic reperfusion after cardiac arrest augments brain-derived neurotrophic factor activation. 
  • Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registry. 
  • Implementation of a billable transitional care model for stroke patients: the COMPASS study. 
  • Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. 
  • Improvement in use of anticoagulation therapy in patients with ischemic stroke: results from Get With The Guidelines-Stroke. 
  • In older persons at risk for dementia, a multidomain approach reduced stroke and transient ischemic attack. 
  • Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease. 
  • Incidence of cerebral ischemic events after discontinuation of clopidogrel in patients with intracranial aneurysms treated with stent-assisted techniques. 
  • Increased oxygen extraction fraction is associated with prior ischemic events in patients with carotid occlusion. 
  • Independent predictors of stroke in patients with atrial fibrillation: a systematic review. 
  • Indium-111 platelet scintigraphy in cerebrovascular disease. 
  • Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy: A Post Hoc Analysis of a Randomized Clinical Trial. 
  • Inpatient costs of specific cerebrovascular events at five academic medical centers. 
  • Intraischemic nitrous oxide alters neither neurologic nor histologic outcome: a comparison with dizocilpine. 
  • Intraoperative physiologic variables and outcome in cardiac surgery: Part II. Neurologic outcome. 
  • Is this patient having a stroke? 
  • Ischemic injury and extracellular amino acid accumulation in hippocampal area CA1 are not dependent upon an intact septo-hippocampal pathway. 
  • LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA. 
  • Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. 
  • Lack of impact of paramedic training and use of the cincinnati prehospital stroke scale on stroke patient identification and on-scene time. 
  • Lesions of excitatory pathways reduce hippocampal cell death after transient forebrain ischemia in the gerbil. 
  • Letter by El Husseini et al regarding article, "What causes disability after transient ischemic attack and minor stroke?". 
  • Letter by Moris et al Regarding Article, "One-Year Outcomes After Minor Stroke or High-Risk Transient Ischemic Attack: Korean Multicenter Stroke Registry Analysis". 
  • Letter by Moris et al Regarding Article, "Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)". 
  • Lipids and stroke: a paradox resolved. 
  • Long-term neuroprotection by benzodiazepine full versus partial agonists after transient cerebral ischemia in the gerbil [corrected]. 
  • Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. 
  • Low yield in the diagnostic evaluation of transient ischemic attacks. 
  • Management of moyamoya syndrome in patients with Noonan syndrome. 
  • Medical treatment for stroke prevention. 
  • Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia. 
  • Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. 
  • Monitoring and improving acute stroke care: The North Carolina Stroke Care Collaborative. 
  • Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. 
  • Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. 
  • Neurologic manifestations of essential thrombocythemia. 
  • Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients. 
  • New transient ischemic attack and stroke: outpatient management by primary care physicians. 
  • Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia/reperfusion. 
  • Non-atherosclerotic vascular disease in the young. 
  • Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack. 
  • Off-label closure during CLOSURE study. 
  • Optical imaging of hippocampal neurons with a chloride-sensitive dye: early effects of in vitro ischemia. 
  • Outcomes Associated With Familial Versus Nonfamilial Atrial Fibrillation: A Matched Nationwide Cohort Study. 
  • Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD2 score. 
  • P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients With Minor Stroke or High-Risk Transient Ischemic Attack. 
  • P2Y12 receptor inhibitors for secondary prevention of ischemic stroke. 
  • Papillary fibroelastoma of the aortic valve. 
  • Perioperative management of aneurysmal subarachnoid hemorrhage: Part 2. Postoperative management. 
  • Perioperative morbidity and mortality in combined vs. staged approaches to carotid and coronary revascularization. 
  • Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. 
  • Periprocedural complication rates are equivalent between symptomatic and asymptomatic patients undergoing carotid angioplasty and stenting. 
  • Pharmacological correction of hypothermic P(50) shift does not alter outcome from focal cerebral ischemia in rats. 
  • Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. 
  • Positron emission tomography and its application to the study of cerebrovascular disease in man. 
  • Positron emission tomography in cerebrovascular disease. 
  • Positron emission tomography to assess cerebral perfusion. 
  • Postischemic synaptic physiology in area CA1 of the gerbil hippocampus studied in vitro. 
  • Pre-ischemic depletion of brain norepinephrine decreases infarct size in normothermic rats exposed to transient focal cerebral ischemia. 
  • Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. 
  • Predictors of Outcomes in Patients With Mild Ischemic Stroke Symptoms: MaRISS. 
  • Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. 
  • Prevention and health services delivery. 
  • Prevention of chronic cerebral vasospasm in dogs with milrinone. 
  • Primary care physician-reported secondary and tertiary stroke prevention practices. A comparison between the United States and the United Kingdom. 
  • Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death. 
  • Prolonged Cardiac Monitoring and Stroke Recurrence: A Meta-analysis. 
  • Prolonged production of hydroxyl radical in rat hippocampus after brain ischemia-reperfusion is decreased by 21-aminosteroids. 
  • Protection against focal cerebral ischemia following exposure to a pulsed electromagnetic field. 
  • Protocol for a feasibility randomised controlled trial of Screening and Enhanced Risk management for Vascular Event-related Decline in Memory (SERVED Memory). 
  • Quality of Care and Ischemic Stroke Risk After Hospitalization for Transient Ischemic Attack: Findings From Get With The Guidelines-Stroke. 
  • Quality of Care for Veterans With Transient Ischemic Attack and Minor Stroke. 
  • Quantitative regional brain water measurement with magnetic resonance imaging in a focal ischemia model. 
  • Race, presenting signs and symptoms, use of carotid artery imaging, and appropriateness of carotid endarterectomy. 
  • Racial inequity of access to carotid imaging. 
  • Racial variation in treatment for transient ischemic attacks: impact of participation by neurologists. 
  • Racial variations in the rates of carotid angiography and endarterectomy in patients with stroke and transient ischemic attack. 
  • Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial. 
  • Rapid decline of GABAA receptor subunit mRNA expression in hippocampus following transient cerebral ischemia in the gerbil. 
  • Rapid down-regulation of GABAA receptors in the gerbil hippocampus following transient cerebral ischemia. 
  • Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS. 
  • Recurrent transient ischemic attacks and stroke associated with an internal carotid artery web. 
  • Recurrent transient ischemic attacks and stroke in association with an internal carotid artery web. 
  • Regional variation in recommended treatments for ischemic stroke and TIA: Get with the Guidelines--Stroke 2003-2010. 
  • Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil. 
  • Relation of Admission Blood Pressure to In-hospital and 90-Day Outcomes in Patients Presenting With Transient Ischemic Attack. 
  • Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. 
  • Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat. 
  • Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and Beyond. 
  • Response by Powers and Rabinstein to Letter Regarding Article, "2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association". 
  • Risk factor profile and management of cerebrovascular patients in the REACH Registry. 
  • Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial. 
  • Risk of ischemic heart disease in patients with TIA. 
  • Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. 
  • Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. 
  • Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. 
  • Role of Doppler US in screening for carotid atherosclerotic disease. 
  • SUMO2/3 conjugation is an endogenous neuroprotective mechanism. 
  • Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis. 
  • Selective neocortical and thalamic cell death in the gerbil after transient ischemia. 
  • Selective neuronal death after transient forebrain ischemia in the Mongolian gerbil: a silver impregnation study. 
  • Sex differences in neurological outcomes and mortality after cardiac surgery: a society of thoracic surgery national database report. 
  • Sex differences in quality of life after ischemic stroke. 
  • Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways. 
  • Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). 
  • Statins and the Risk of Intracerebral Hemorrhage in Patients With Previous Ischemic Stroke or Transient Ischemic Attack. 
  • Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2-VASc Scores: Findings From the ORBIT-AF I and II Registries. 
  • Stroke in Patients With Peripheral Artery Disease. 
  • Stroke mechanisms and outcomes of isolated symptomatic basilar artery stenosis. 
  • Stroke prevention: the emerging strategies. 
  • Stroke: Organizing the disorganized: improving TIA patient care. 
  • Symptomatic cerebral vasospasm following tumor resection: report of two cases. 
  • TIA, stroke, and the bicuspid aortic valve. 
  • The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trial. 
  • The effects of aprotinin on outcome from cerebral ischemia in the rat. 
  • The impact of intraoperative shunting on early neurologic outcomes after carotid endarterectomy. 
  • The importance of family history in cerebrovascular disease. 
  • The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. 
  • The rational clinical examination. Clinical assessment of stroke. 
  • The safety of aeroplane travel in patients with symptomatic carotid occlusion. 
  • The use of locomotor activity as a behavioral screen for neuronal damage following transient forebrain ischemia in gerbils. 
  • The value of carotid endarterectomy in treating transient cerebral ischemia of the posterior circulation. 
  • Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack. 
  • Transient focal cerebral ischemia induces a dramatic activation of small ubiquitin-like modifier conjugation. 
  • Transient global cerebral ischemia induces a massive increase in protein sumoylation. 
  • Transient ischemic attack and acute ischemic stroke: associations with retinal microvascular signs. 
  • Transient ischemic attacks in a man with coronary artery disease: two strategies neck and neck. 
  • Transradial access for carotid artery stenting: a single-center experience. 
  • Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack. 
  • US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Carotid endarterectomy. 
  • Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. 
  • Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's Get with the Guidelines--Coronary Artery Disease database). 
  • When and how to study the carotid arteries. 
  • Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial. 
  • [Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology]. 
  • [Carotid stenting with the new slotted tube stent--prospective multicenter study. Essen experiences]]. 
• 

  Keywords of People

  • Laskowitz, Daniel Todd, Professor of Neurology, Duke Science & Society
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
  • Schwartz-Bloom, Rochelle D., Professor Emeritus of Pharmacology & Cancer Biology, Duke Science & Society